Dr Ramdial on Gemcitabine/Clofarabine/Busulfan for Lymphoma

Jeremy L. Ramdial, MD, discusses the myeloablative conditioning regimen gemcitabine, clofarabine, and busulfan in patients with aggressive lymphomas.

Related Keywords

Corrs , Texas , United States , Jeremyl Ramdial , , University Of Texas Md Anderson Cancer Center , Division Of Cancer Medicine , Department Of Stem Cell Transplantation , Stem Cell Transplantation , Cellular Therapy , Cancer Medicine , Cancer Center , D , The University Of Texas Md Anderson Cancer Center , Gemcitabine , Lofarabine And Busulfan , Patients With Aggressive Lymphomas ,